Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancerJin Hwa Hong, Yikyeong Chun, Yung‐Taek Ouh et al.|Journal of Gynecologic Oncology|2022Cited by 23
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) datasetJin Hwa Hong, Jeong‐An Gim, Yung‐Taek Ouh et al.|Journal of Gynecologic Oncology|2022Cited by 21